UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE...
ULURU Inc. Reports Third Quarter 2011 Financial Results PR Newswire ADDISON, Texas, Nov. 15, 2011 ADDISON, Texas, Nov. 15, 2011 /PRNewswire/...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report Pursuant to Section 13 or 15(d) of...
ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2011 and to Provide a Business...
ULURU Inc. Announces Additional Data Supporting Altrazeal® Use in Diabetic Foot Ulcers - Offers Potential for Significant Savings and Improved...
ULURU Inc. Announces Altrazeal® Agreement for the European Market - Launch Anticipated in Germany Early 2012- - Initial Licensing Fees...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
ULURU Inc. Receives NYSE Amex Notice of Non-Compliance with Continued Listing Standards PR Newswire ADDISON, Texas, Sept. 27, 2011 ADDISON...
Prospectus Supplement Filed Pursuant to Rule 424(b)(5) (to Prospectus dated July 23, 2009) Registration...
The information contained in this prospectus is not complete and may be changed. We may not sell these securities until the registration...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE...
ULURU Inc. Enters Into Strategic Financings of Up to $1.6 Million at a Premium to Current Share Price PR Newswire ADDISON, Texas, Sept. 15, 2011...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.